Metabolism of N-[4-hydroxyphenyl]retinamide (4-HPR) to N-[4-methoxyphenyl]retinamide (4-MPR) may serve as a biomarker for its efficacy against human breast cancer and melanoma cells

✍ Scribed by R.R. Mehta; M.E. Hawthorne; J.M. Graves; R.G. Mehta

• Book ID: 117665763
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 131 KB
• Volume: 34
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(98)00032-x